Clovis lacks the scientfice bona fides to invent oncology meds. Clovis is a hedge fund without technical skills.
See the CNBC video from Monday, 2 Jun 2014 | 4:32 PM ET
Clovis Oncology CEO Patrick J. Mahaffy "You compete on data", he says.
Can you pronounce Astra Zeneca now?
Sentiment: Strong Sell